The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Tumor perfusion during bevacizumab and irinotecan in recurrent glioblastoma: A multimodal approach.
Marica Eoli
No relevant relationships to disclose
Anna Luisa Di Stefano
No relevant relationships to disclose
Domenico Aquino
No relevant relationships to disclose
Alessandro Scotti
No relevant relationships to disclose
Elena Anghileri
No relevant relationships to disclose
Lucia Cuppini
No relevant relationships to disclose
Elena Prodi
No relevant relationships to disclose
Gaetano Finocchiaro
No relevant relationships to disclose
Maria Grazia Bruzzone
No relevant relationships to disclose